港股跌幅擴至逾450點失守26,300 藥明生物及小米挫5.5%-6% 匯控續跌逾2%屢尋底
聯儲局如期維持利率不變,並料低息將持續至後年底及強調仍有工具撐經濟復甦,但美國8月零售銷售遜預期,加上大型科網股重現沽壓。美股期貨跌幅全面擴至1.1%-1.5%,昨晚倒跌逾1%的納指一百期貨續跑輸,報11,086,續挫168點及1.5%;道指期貨回吐299點或1.1%報27,637。亞太區股市除星股逆穩外,全部受壓,未能受惠8月失業率意外由前值所創近19年高位7.5%急降至6.8%的澳洲200吐1.1%報5,891;滬深股市吐近1%。
港股扭三連升,今早低開49點,跌幅曾持續擴至474點,低見24,250,現造24,265,急挫460點或近1.9%,成交額632億元。
藍籌股普遍向下,本月三隻恆指新貴以日前遭副主席大幅減持小米-W(01810.HK)最傷,最低見21.2元,現造21.35元,急挫6.2%;藥明生物(02269.HK)續吐5.5%報182元,股價一舉失守10天及20天線;阿里巴巴-WW(09988.HK)也失守10天及20天線,最低見265.6元,現造266.4元,跌2.4%。重磅股騰訊(00700.HK)扭五連漲,股價反覆吐1.9%報524.5元,失守20天及50天線。
蘋果昨晚挫3%,瑞聲(02018.HK)三連跌報45.75元,續跌1.8%,但舜宇(02382.HK)逆彈1.3%報124.9元。此外,出口股創科(00669.HK)及申洲(02313.HK)分別回吐4%及續吐2.6%,分別報99.5元及127.7元。
金融股以匯控(00005.HK)及友邦(01299.HK)沽壓最大,股價續跌2.4%,分別低見30.85元(再創金融海嘯以來新低)及78.8元。地產收租股以恆隆地產(00101.HK)、九倉置業(01997.HK)及新世界(00017.HK)沽壓最大,股價跌近2%-2.5%。不過,新地(00016.HK)及港鐵(00066.HK)反覆升0.4%及1.9%,後者報40.5元。此外,「三桶油」隨外圍同業升0.9%-1.3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.